A New Approach for the Prophylactic Improvement of Surgical Scarring: Avotermin (TGFβ3)

Clinics in Plastic Surgery

Volumn 36, Issue 2, 2009, Pages 307-313

  Young, V Leroy ^a   Bush, James ^b   O'Kane, Sharon ^b  

^a BodyAesthetic Plastic Surgery and Skincare Center   (United States)

^b Renovo   (United Kingdom)

Author keywords

Avotermin; Cicatrix; Scarring; Surgery; Transforming growth factor 3

Indexed keywords

CICATRIX; HUMANS; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; RECONSTRUCTIVE SURGICAL PROCEDURES; TRANSFORMING GROWTH FACTOR BETA3;

EID: 62549105323     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2008.11.008     Document Type: Review

References (20)

1. Rumsey N., Clarke A., and White P. Exploring the psychosocial concerns of outpatients with disfiguring conditions. J Wound Care 12 7 (2003) 247-252
2. Bisson J.I., Shepherd J.P., and Dhutia M. Psychological sequelae of facial trauma. J Trauma 43 3 (1997) 496-500
3. Young V.L., and Hutchison J. Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys. Plast Reconstr Surg (2009) in press
4. Shepherd J.P., Qureshi R., Preston M.S., et al. Psychological distress after assaults and accidents. BMJ 301 6756 (1990) 849-850
5. Ferguson M.W., and O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 359 1445 (2004) 839-850
6. American Society of Plastic Surgeons. Plastic surgery growth in 2007. Available at:. http://www.plasticsurgery.org/media/statistics/index.cfm Accessed October 6, 2008
7. Bayat A., and McGrouther D.A. Clinical management of skin scarring. Skinmed 4 3 (2005) 165-173
8. Mustoe T.A., Cooter R.D., Gold M.H., et al. International clinical recommendations on scar management. Plast Reconstr Surg 110 2 (2002) 560-571
9. Reish R.G., and Eriksson E. Scars: a review of emerging and currently available therapies. Plast Reconstr Surg 122 4 (2008) 1068-1078
10. Reish R.G., and Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg 206 4 (2008) 719-730
11. Durani P., and Bayat A. Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg 61 1 (2008) 4-17
12. Whitby D.J., and Ferguson M.W. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 147 1 (1991) 207-215
13. Shah M., Foreman D.M., and Ferguson M.W. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 339 8787 (1992) 213-214
14. Shah M., Foreman D.M., and Ferguson M.W.J. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108 (1995) 985-1002
15. Shah M., Foreman D.M., and Ferguson M.W. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107 Pt 5 (1994) 1137-1157
16. Bandyopadhyay B., Fan J., Guan S., et al. A traffic control role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol 172 7 (2006) 1093-1105
17. Chen W., Fu X., Ge S., et al. Ontogeny of expression of transforming growth factor-beta and its receptors and their possible relationship with scarless healing in human fetal skin. Wound Repair Regen 13 1 (2005) 68-75
18. O'Kane S., and Ferguson M.W.J. Transforming growth factor betas and wound healing. Int J Biochem Cell Biol 29 1 (1997) 63-78
19. Occleston N.L., Laverty H.G., O'Kane S., et al. Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGFβ3): from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 7 3 (2008) 1047-1063
20. Durani P., Occleston N., O'Kane S., et al. Avotermin: a novel antiscarring agent. Int J Low Extrem Wounds 7 3 (2008) 160-168